First patients vaccinated in clinical trial of HIV experimental vaccine that uses Moderna's mRNA technology
CTV
The first participants have been vaccinated in a Phase 1 clinical trial of an experimental HIV vaccine that utilizes Moderna's mRNA technology, the company announced last week.
The trial, titled IAVI G002, is being conducted in partnership IAVI, a nonprofit scientific research organization. It is testing a vaccine that delivers HIV-specific antigens to the body with the goal of inducing an immune response. These antigens were initially developed by researchers at IAVI and Scripps Research, led by Dr. William Schief.
In a "proof-of-concept" trial last year, the research team found the HIV antigens produced the desired immune response in 97% of participants. The current trial builds on the previous one by testing the primary version of the vaccine and also a booster version, and by employing Moderna's mRNA technology, which was previously used to create a successful COVID-19 vaccine.
"We are tremendously excited to be advancing this new direction in HIV vaccine design with Moderna's mRNA platform. The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be the key to making rapid progress toward an urgently needed, effective HIV vaccine," Mark Feinberg, IAVI's president and CEO, said in a news release from Moderna.
The new trial, funded in part by the Bill & Melinda Gates Foundation, will follow 56 HIV-negative adult participants, with the goal of studying both the safety and efficacy of the vaccine. Forty-eight of the volunteers will receive at least one dose of the primary vaccine, 32 of which will also receive the booster. The remaining eight will receive the booster vaccine alone.
Northvolt AB has filed for bankruptcy protection in the United States, but said the move will not jeopardize the manufacturer's planned electric vehicle battery plant in Quebec — though hundreds of millions of taxpayer dollars invested in the parent company could be lost.
A popular series of Murphy beds that had been sold online is under a recall in Canada and the U.S. after several reported instances of the furniture detaching from walls.
Even though sales of electric vehicles aren't growing as fast as in past years and President-elect Donald Trump may ditch tax credits for EV buyers, automakers are moving ahead with new models that should appeal to mainstream buyers.
Countries of the world took turns rejecting a new but vague draft text released early Thursday which attempts to form the spine of any deal reached at United Nations climate talks on money for developing countries to transition to clean energy and adapt to climate change.
The Canadian Space Agency (CSA) is inviting Canadians to choose the name of the first Canadian Lunar Rover.
A Dallas anesthesiologist was sentenced Wednesday to 190 years in prison for injecting a nerve-blocking agent and other drugs into bags of intravenous fluid at a surgical center where he worked, leading to the death of a coworker and causing cardiac emergencies for several patients.
CTVNews.ca wants to hear from digital nomads who have taken up location-independent jobs and can work from anywhere with an internet connection.
In Canada a car is stolen every six minutes, though some vehicles are more sought after than others.
A major storm swept across the northwest U.S., battering the region with strong winds and rain, causing widespread power outages and downing trees that killed at least one person.
SpaceX on Tuesday launched another Starship rocket, but passed up catching the booster with giant mechanical arms.
Caring for a senior pet is no walk in the park, especially when the pet can't walk at all. A Colorado woman was shocked to find her dog's wheelchair missing from the porch Tuesday morning